Stay updated on CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Sign up to get notified when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.

Latest updates to the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record for CT-P13 in patients with active rheumatoid arthritis is displayed, including its study design, eligibility criteria, outcomes, and results-related information. Study publications, record dates, and protocol and statistical analysis plan documents are also shown.SummaryDifference58%

- Check9 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2. The study record itself continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA banner announces NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page now shows a formal 403 Forbidden error page with the standard header and footer, replacing the previous generic 'This site can't be reached' message.SummaryDifference100%

Stay in the know with updates to CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT-P13 SC vs IV in RA: Efficacy, PK, Safety Clinical Trial page.